tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Annabel Samimy, 180 are a BUY (81.08%), 42 are a HOLD (18.92%).
Analyst Annabel Samimy, currently employed at STIFEL, carries an average stock price target met ratio of 56.8% that have a potential upside of 43.16% achieved within 302 days.
Annabel Samimy’s has documented 375 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EOLS, Evolus at 13-Jan-2026.
Analyst best performing recommendations are on VKTX (VIKING THERAPEUTICS).
The best stock recommendation documented was for EOLS (EVOLUS) at 1/28/2019. The price target of $27 was fulfilled within 10 days with a profit of $12.01 (80.12%) receiving and performance score of 80.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Aug-2022
$13
3 years 5 months 1 days ago
(29-Aug-2022)
1/5 (20%)
$4.7 (56.63%)
176
Hold Since 24-Aug-2022
3 years 5 months 6 days ago
(24-Aug-2022)
0/1 (0%)
$6.53 (25.64%)
Hold Since 24-Aug-2022
$20
3 years 5 months 6 days ago
(24-Aug-2022)
0/4 (0%)
$14.21 (245.42%)
Buy Since 19-Mar-2014
$15.25
$27
3 years 5 months 7 days ago
(23-Aug-2022)
7/11 (63.64%)
$0.09 (0.59%)
149
Hold Since 23-Aug-2022
$14
3 years 5 months 7 days ago
(23-Aug-2022)
6/14 (42.86%)
$6.36 (83.25%)
228
Which stock is Annabel Samimy is most bullish on?
Which stock is Annabel Samimy is most reserved on?
What Year was the first public recommendation made by Annabel Samimy?
